Ticker	Volume	Price	Price Delta
DJIA	15,387.60	+52.30	0.34%
S&P 500	1,669.16	+2.87	0.17%
Nasdaq	3,502.12	+5.69	0.16%

Ticker

Volume

Price

Price Delta

DJIA

15,387.60

+52.30

0.34%

S&P 500

1,669.16

+2.87

0.17%

Nasdaq

3,502.12

+5.69

0.16%

Ticker	Volume	Price	Price Delta
STOXX 50	2,821.65	-2.85	-0.10%
FTSE 100	6,803.87	+48.24	0.71%
DAX	8,472.20	+16.37	0.19%

Ticker

Volume

Price

Price Delta

STOXX 50

2,821.65

-2.85

-0.10%

FTSE 100

6,803.87

+48.24

0.71%

DAX

8,472.20

+16.37

0.19%

Ticker	Volume	Price	Price Delta
Nikkei	15,660.10	+279.06	1.81%
Hang Seng	23,300.50	-65.86	-0.28%
S&P/ASX 200	5,161.70	-18.36	-0.35%

Ticker

Volume

Price

Price Delta

Nikkei

15,660.10

+279.06

1.81%

Hang Seng

23,300.50

-65.86

-0.28%

S&P/ASX 200

5,161.70

-18.36

-0.35%

Prolor Biotech Falls to Three-Week Low as Quarterly Loss Widens

By Shoshanna Solomon - 2012-05-06T08:42:48Z

Prolor Biotech Inc. (PBTH) declined to the lowest level in almost three weeks after the developer of therapeutic proteins said its first-quarter loss widened.

The shares dropped 2.6 percent to 19.90 shekels at 10:42 a.m. in Tel Aviv, the lowest intraday level since April 16, giving the company a market value of 1.09 billion shekels ($287 million). The TA-25 index declined 1.5 percent today.

Prolor’s loss widened to $4.99 million from $3.46 million in the same period last year.

To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at ssolomon22@bloomberg.net

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.